CB-693

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameCB-693
Drug Alias NameCB-693
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionMesothelin inhibitorsTumor necrosis factor receptor superfamily member 9 agonists
TargetsMesothelinTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrescendo Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCrescendo Biologics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A